An interventional study of Non-surgical Periodontal Treatment in Rheumatoid Arthritis (RA), Periodontitis and Gingivitis, sponsored by Ondokuz Mayıs University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-28.
Sponsored by Ondokuz Mayıs University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 128 studies in Arthritis, Rheumatoid with a site in Turkey — 14 open to participants now, 19 under way, 2 of them phase 3. Arthritis, Rheumatoid · Turkey.
Among the 128 studies in Arthritis, Rheumatoid with a site in Turkey, this one is the 55th largest by enrollment of the 78 interventional ones that give a count, is one of 18 that started in 2025, is one of 44 with no phase, and was the 125th registered.
3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.
Browse Arthritis, Rheumatoid studies →14 of the 128 studies in Arthritis, Rheumatoid with a site in Turkey are open now. Recruiting first, the newest first:
Merve Şahin · Sites in Turkey
Ages 18–65 · Healthy volunteers
Medipol University · Sites in Turkey
Ages 20–65
Hasan Kalyoncu University · Sites in Turkey
Ages 19–65
TIPMED Medical Device Manufacturing Ltd. Co. · Sites in Turkey
Ages 18+
Firat University · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 293 Arthritis, Rheumatoid studies recruiting now, 151 (52%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
128 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 9 · Phase 3 20 · Phase 4 7
First in 2001; this study’s year is marked. 18 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 54 is below the median of 96 across 2,226 interventional studies indexed under Arthritis, Rheumatoid.
Median enrollment 77 across the 78 interventional studies, 100 across the 50 observational. Of the 99 that completed or were terminated, 31 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
38 of 128 have an industry lead sponsor. The 10 most frequent:
Ondokuz Mayıs University is the lead sponsor of 281 studies on the registry; 64 are open to participants now.
Ondokuz Mayıs University has 1 study filed under Arthritis, Rheumatoid — fewer than ten, so there is no comparison to draw.
3 of the studies in Arthritis, Rheumatoid with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07627542Merve ŞahinAn Investigation of the Effect of Smartphone Usage Levels on Cervical Posture, Tongue Pressure, Balance, and Neck Disability in Individuals With Rheumatoid Arthritis and Ankylosing Spondylitis | 2026-11 |
| NCT07666594Tugba Civi KaraaslanMobile App-Based Yoga and Meditation in Rheumatoid Arthritis | 2027-05 |
| NCT07274124Medipol UniversityPain Neuroscience Education and Vagus Nerve Stimulation on Recovery in Individuals With Rheumatoid Arthritis | 2027-05 |
Add all 3 to your calendar (.ics) → With an account.
Among the 128 studies in Arthritis, Rheumatoid with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study evaluates the relationship between rheumatoid arthritis and periodontal health and examines the effects of nonsurgical periodontal treatment on clinical periodontal findings and gingival crevicular fluid biomarkers. Participants with and without rheumatoid arthritis were classified according to periodontal status as periodontally healthy, gingivitis, or periodontitis. Clinical periodontal measurements and gingival crevicular fluid levels of calprotectin (MRP-8/14) and interleukin-10 (IL-10) were evaluated at baseline, 1 month, and 3 months. Disease Activity Score-28 (DAS28) was also evaluated in participants with rheumatoid arthritis.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Voluntary participation in the study. Aged 18 to 65 years. For participants in the rheumatoid arthritis groups, diagnosis of rheumatoid arthritis at least 1 year before enrollment.
For participants in the systemically healthy groups, absence of any systemic disease that may affect periodontal tissues.
No periodontal treatment within the previous 6 months. No local or systemic antibiotic use within the previous 3 months. Never having smoked or having stopped smoking at least 2 years before enrollment.
For participants in the periodontally healthy control groups, no history of periodontal disease and the presence of good oral hygiene.
Exclusion Criteria:
Unwillingness to participate in the study. Age younger than 18 years or older than 65 years. Presence of any systemic disease other than rheumatoid arthritis that may affect periodontal tissues.
Local or systemic antibiotic use within the previous 3 months. Periodontal treatment within the previous 6 months. Pregnancy or lactation. Use of medications that may affect gingival tissues, including calcium channel blockers, phenytoin, cyclosporine, or hormone replacement therapy.
Receiving biological treatment for rheumatoid arthritis, such as anti-tumor necrosis factor therapy.
Current smoking.
Participants with rheumatoid arthritis and periodontitis receive non-surgical periodontal treatment. This arm includes 9 participants.
Procedure: Non-surgical Periodontal Treatment
Systemically healthy participants with periodontitis receive non-surgical periodontal treatment. This arm includes 9 participants.
Procedure: Non-surgical Periodontal Treatment
Participants with rheumatoid arthritis and gingivitis receive non-surgical periodontal treatment. This arm includes 9 participants.
Procedure: Non-surgical Periodontal Treatment
Systemically healthy participants with gingivitis receive non-surgical periodontal treatment. This arm includes 9 participants.
Procedure: Non-surgical Periodontal Treatment
Participants with rheumatoid arthritis and periodontal health receive no periodontal treatment and serve as a comparison group. This arm includes 9 participants.
Systemically and periodontally healthy participants receive no periodontal treatment and serve as a comparison group. This arm includes 9 participants.
The intervention consists of oral hygiene instructions, full-mouth scaling, and subgingival instrumentation and root planing where clinically indicated. It is administered to participants with periodontitis or gingivitis after baseline assessments. Periodontally healthy groups receive no periodontal treatment.
Also known as: NSPT
Change in Gingival Crevicular Fluid Calprotectin (MRP-8/14) Levels
Gingival crevicular fluid calprotectin (MRP-8/14) levels were measured using an enzyme-linked immunosorbent assay (ELISA). Changes in calprotectin levels were evaluated over time and compared according to rheumatoid arthritis status and periodontal condition.
Time frame: Baseline, 1 month, and 3 months
Change in Gingival Crevicular Fluid Interleukin-10 (IL-10) Levels
Gingival crevicular fluid interleukin-10 (IL-10) levels were measured using an enzyme-linked immunosorbent assay (ELISA). Changes in IL-10 levels were evaluated over time and compared according to rheumatoid arthritis status and periodontal condition.
Time frame: Baseline, 1 month, and 3 months
Change in Probing Pocket Depth
Probing pocket depth was measured in millimeters using a periodontal probe as the distance from the gingival margin to the base of the periodontal pocket. Changes were evaluated over time according to rheumatoid arthritis status and periodontal condition.
Time frame: Baseline, 1 month, and 3 months
Change in Clinical Attachment Level
Clinical attachment level was measured in millimeters using a periodontal probe as the distance from the cementoenamel junction to the base of the periodontal pocket. Changes were evaluated over time according to rheumatoid arthritis status and periodontal condition.
Time frame: Baseline, 1 month, and 3 months
Change in Bleeding on Probing
Bleeding on probing was recorded as present or absent following gentle periodontal probing and expressed as the percentage of sites with bleeding. Changes were evaluated over time according to rheumatoid arthritis status and periodontal condition.
Time frame: Baseline, 1 month, and 3 months
Change in Plaque Index
Plaque accumulation was assessed using the Plaque Index. Changes in plaque scores were evaluated over time according to rheumatoid arthritis status and periodontal condition.
Time frame: Baseline, 1 month, and 3 months
Change in Gingival Index
Gingival inflammation was assessed using the Gingival Index. Changes in gingival index scores were evaluated over time according to rheumatoid arthritis status and periodontal condition.
Time frame: Baseline, 1 month, and 3 months
Change in Gingival Crevicular Fluid Volume
Gingival crevicular fluid volume was measured using Periopaper strips and a calibrated Periotron 8000 device. Changes in gingival crevicular fluid volume were evaluated over time according to rheumatoid arthritis status and periodontal condition.
Time frame: Baseline, 1 month, and 3 months
Change in Disease Activity Score-28 (DAS28)
Disease activity was evaluated in participants with rheumatoid arthritis using the Disease Activity Score-28 (DAS28). Changes in DAS28 scores were assessed following nonsurgical periodontal treatment.
Time frame: Baseline and 3 months
Ran from Jul 2025 to primary completion in May 2026, 9 months.
Of 293 non-industry interventional studies with no phase under Arthritis, Rheumatoid, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 39. This study's 9 months is below that.
Counting every sponsor, half of 349 studies reached it within 27 months; a quarter within 13 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.